Clinical Trials Directory

Trials / Completed

CompletedNCT02749487

Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients

Neutrophil Lymphocyte and Platelet Lymphocyte Ratios as Predictors of Outcome in Traumatic Critically Ill Patients

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Neutrophil lymphocyte ratio NLR is an important index that evaluate the inflammatory status . It is a cost effective and readily available , and simply calculated , so that why investigators try to use it as a predictor of short term survival in the critically ill patients

Detailed description

NLR will be used as predictor for short term survival and patients stay in ICU in 2 groups of patients . Investigators will use it in a group of Medical Critically ill patients as respiratory failure , neuromuscular disorders , renal impairment . the other group is the critically ill surgical patients , as patients with multiple trauma , post major surgery

Conditions

Interventions

TypeNameDescription
OTHERNeutrophil Lymphocyte RatioNeutrophil:lymphocyte ratio (NLR) is an emerging biomarker that is used to predict mortality and morbidity. The association of this biomarker with systemic illness and its usefulness in risk assessment of critically ill patients has not been fully elucidated.

Timeline

Start date
2015-06-01
Primary completion
2016-05-01
Completion
2016-09-01
First posted
2016-04-25
Last updated
2016-12-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02749487. Inclusion in this directory is not an endorsement.